Boasting strong patient enrollment rates, naive patient populations, enthusiastic physicians and a favorable cost structure – Belarus has much to offer life science companies as a location for clinical trials. These benefits, combined with the low number of trials currently being conducted, means that Belarus is an undiscovered gem for savvy clinical trial managers.
In this whitepaper, presented by Pharm-Olam International, you will learn:
Why Belarus is considered “An Undiscovered Gem”
The approval process for conducting clinical trials in Belarus
Information on the healthcare system, approval processes, import/export licenses and patient recruitment procedures in Belarus